Tag: Colorectal Cancer
-
Bantry Opens €8m Endoscopy Unit as CUH Expands BowelScreen Services
New Endoscopy Facility in Bantry Opens Amid BowelScreen Expansion A new €8 million endoscopy unit in Bantry has officially opened, marking a significant milestone for Cork University Hospital (CUH) and its ongoing expansion of the national BowelScreen program. The state-of-the-art facility is designed to streamline bowel cancer screening and diagnostic procedures for residents across west…
-
Ultra-Processed Foods Linked to Precancerous Polyps in Women
Overview: What the new findings show A recent study published in JAMA Oncology examines the relationship between ultra-processed foods and the risk of precancerous colorectal polyps, with a focus on women under 50. The research analyzed health data from tens of thousands of participants to understand how dietary patterns—specifically the consumption of ultra-processed foods—might influence…
-
Poopular Science: AI toilets get to the bottom of your gut health
Smart toilets, smart health Your morning routine could become a daily health check, thanks to sensors and artificial intelligence that analyze stool characteristics like color, shape, and consistency. Rather than merely flushing away waste, modern toilet technology is poised to provide early warnings about digestive health, hydration, and potential disease risks. This fusion of hygiene…
-
Hospitalization Spending on Cancers in Hunan, China (2017–2019): A Comprehensive Look at Costs and Determinants
Overview Cacing the economic burden of cancer requires looking beyond incidence and mortality to how hospitalization costs accumulate. A retrospective study using the CNHSNRS data from 2017–2019 in Hunan Province, China, quantified inpatient spending for all cancers, described the cost distribution across cancer sites and patient characteristics, and identified factors associated with higher per-admission costs.…
-
Hospitalization Costs for Cancers in Hunan, China (2017–2019): An In-Depth Look at Economic Burden and Driving Factors
Overview: The Economic Burden of Cancer in Hunan (2017–2019) The hospitalization expenditure for cancers in Hunan Province, China, from 2017 through 2019 reached US$2,490.36 million, illustrating a substantial economic burden on patients, insurers, and the health system. Across 872,309 cancer-related hospitalizations, medical insurance covered 64.10% of costs, while out-of-pocket payments accounted for 35.90%. These figures…
-
Colon cancer: US doctor urges a simple test that can save your life
Colon cancer alarms and the power of early detection Colon cancer remains a major global health challenge. The World Health Organization warns that this disease could affect millions in the coming decades, highlighting the urgent need for accessible screening and early intervention. In the United States, a prominent physician has spotlighted a straightforward, life-saving screening:…
-
Colon cancer: This simple test can save your life, says a top US doctor
Colon cancer is a major threat—but early detection can turn the odds in your favor Colorectal cancer, which includes colon cancer, remains a leading cause of cancer deaths worldwide. The World Health Organization projects 1.6 million deaths and 3.2 million new cases annually by 2040, marking a dramatic rise of about 73% from today. Yet…
-
Colon cancer: THIS simple test can save your life, a top US doc says
Colon cancer is on the rise globally, but there’s a powerful, simple tool that saves lives: the colonoscopy Colorectal cancer remains one of the world’s most deadly cancers, with projections showing millions of new cases and deaths in the coming years. The World Health Organization highlights a troubling 1.6 million deaths and 3.2 million new…
-
R-nuucell joins EP PerMed to validate cancer therapy
R-nuucell selected by EP PerMed to validate a promising cancer therapy Portuguese biotechnology startup R-nuucell has been chosen to participate in the European Union’s EP PerMed program, a six-month initiative designed to advance precision medicine for cancer and other diseases. The Lisbon-based company was among eight startups selected for the program, which funds innovative projects…
-
R-nuucell chosen by EU EP PerMed to validate cancer therapy
R-nuucell among eight startups chosen for the EP PerMed six-month program The European program EP PerMed has selected eight innovative biotech ventures to advance personalized medicine, allocating six months of dedicated support and funding. The eight projects cover a range of cancer-related and genetic tools, rehabilitation, and tissue recovery solutions. Among them is the Portuguese…